Probiotics for Prevention and Treatment of Diarrhea
- PMID: 26447963
- DOI: 10.1097/MCG.0000000000000349
Probiotics for Prevention and Treatment of Diarrhea
Abstract
Probiotics are increasingly used for prevention and treatment of diarrhea more in children than in adults. Given the broad spectrum of diarrhea, this review focuses on the main etiologies: acute gastroenteritis, antibiotic-associated diarrhea (AAD), and necrotizing enterocolitis (NEC). For each, we reviewed randomized controlled trials, meta-analyses, and guidelines. For acute gastroenteritis we found 12 guidelines: 5 recommended probiotics and 7 did not. However, the guidelines containing positive recommendations provided proof of evidence from clinical trials and meta-analyses. Lactobacillus rhamnosus GG (LGG) and Saccharomyces boulardii had the most compelling evidence of efficacy as they reduced the duration of the disease by 1 day. For AAD 4 meta-analyses were found, reporting variable efficacy of probiotics in preventing diarrhea, based on the setting, patient's age, and antibiotics. The most effective strains were LGG and S. boulardii. For NEC, we found 3 randomized controlled trials, 5 meta-analyses, and 4 position papers. Probiotics reduced the risk of NEC enterocolitis and mortality in preterm babies. Guidelines did not support a routine use of probiotics and asked for further data for such sensitive implications. In conclusion, there is strong and solid proof of efficacy of probiotics as active treatment of gastroenteritis in addition to rehydration. There is solid evidence that probiotics have some efficacy in prevention of AAD, but the number needed to treat is an issue. For both etiologies LGG and S. boulardii have the strongest evidence. In NEC the indications are more debated, yet on the basis of available data and their implications, probiotics should be carefully considered.
Similar articles
-
Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment.Pharmacol Res. 2018 Feb;128:63-72. doi: 10.1016/j.phrs.2017.08.001. Epub 2017 Aug 19. Pharmacol Res. 2018. PMID: 28827186 Review.
-
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.Cochrane Database Syst Rev. 2015 Dec 22;(12):CD004827. doi: 10.1002/14651858.CD004827.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2019 Apr 30;4:CD004827. doi: 10.1002/14651858.CD004827.pub5. PMID: 26695080 Updated. Review.
-
[Effectiveness and safety of probiotics in children on the basis of clinical trials].Med Wieku Rozwoj. 2012 Jul-Sep;16(3):240-51. Med Wieku Rozwoj. 2012. PMID: 23378402 Review. Polish.
-
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.Cochrane Database Syst Rev. 2011 Nov 9;(11):CD004827. doi: 10.1002/14651858.CD004827.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2015 Dec 22;(12):CD004827. doi: 10.1002/14651858.CD004827.pub4. PMID: 22071814 Updated. Review.
-
[Therapeutic possibilities of probiotics in antibiotic-related diarrhea].MMW Fortschr Med. 2006 Aug 31;148(35-36):28-30. doi: 10.1007/BF03364716. MMW Fortschr Med. 2006. PMID: 16995359 Review. German.
Cited by
-
Harnessing the Health and Techno-Functional Potential of Lactic Acid Bacteria: A Comprehensive Review.Foods. 2024 May 15;13(10):1538. doi: 10.3390/foods13101538. Foods. 2024. PMID: 38790838 Free PMC article. Review.
-
Probiotics, prebiotics, and synbiotics in childhood diarrhea.Braz J Med Biol Res. 2024 Apr 19;57:e13205. doi: 10.1590/1414-431X2024e13205. eCollection 2024. Braz J Med Biol Res. 2024. PMID: 38656071 Free PMC article. Review.
-
Managing infectious diarrhea among young children in community pharmacies in Saudi Arabia and the implications for AMR.Front Pediatr. 2024 Mar 18;12:1342493. doi: 10.3389/fped.2024.1342493. eCollection 2024. Front Pediatr. 2024. PMID: 38562134 Free PMC article.
-
Adjudicative efficacy of Bifidobacterium animalis subsp. lactis BLa80 in treating acute diarrhea in children: a randomized, double-blinded, placebo-controlled study.Eur J Clin Nutr. 2024 Jun;78(6):501-508. doi: 10.1038/s41430-024-01428-6. Epub 2024 Mar 11. Eur J Clin Nutr. 2024. PMID: 38467857 Free PMC article. Clinical Trial.
-
PM-CNN: microbiome status recognition and disease detection model based on phylogeny and multi-path neural network.Bioinform Adv. 2024 Jan 27;4(1):vbae013. doi: 10.1093/bioadv/vbae013. eCollection 2024. Bioinform Adv. 2024. PMID: 38371919 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical